Nariva virus is a virus that belongs to the genus Bunyaviridae, family Bunyaviridae. It is of the ecological group arboviruses and its pathogenicity is unknown in humans. Nariva virus is the causative agent of a disease known as Nariva disease or Nariva encephalitis and affects the human central nervous system.
Nariva disease was first described in 1907 in Brazil, and has since become known in many South American countries, including Argentina, Uruguay and Chile. The virus is transmitted through mosquito bites and causes encephalitis, which can be fatal.
Nariva virus has several serotypes that can cause different forms of disease. Some serotypes may be more pathogenic to humans than others. Overall, Nariva disease is rare and is usually diagnosed in people who live in areas with high mosquito densities.
Treatment for Nariva disease involves the use of antibiotics such as penicillin or cephalosporins. Antiviral drugs such as interferon alpha-2b may also be used. However, since the pathogenicity of Nariva virus is unknown in humans, treatment may be difficult.
One way to prevent Nariva disease is to use mosquito repellent and avoid areas with high mosquito levels. It is also recommended to practice good hygiene, such as using hand wash after contact with mosquitoes or other animals.
Overall, Nariva disease remains a serious problem in some regions of South America, and its prevention and treatment remain important public health goals.